https://www.tga.gov.au/resources/guidance/ctd-module-1-administrative-information-assessed-listed-medicines
CTD Module 1: Administrative information for assessed listed medicines | Therapeutic Goods...
Apr 10, 2026 - Guidance about the administrative information to support assessed listed medicine applications.
assessed listed medicinesadministrative informationctdmodule1
https://www.tga.gov.au/products/medicines/listed-medicines
Listed medicines | Therapeutic Goods Administration (TGA)
Lower risk medicines containing pre-approved, low-risk ingredients and that make limited claims can be listed on the Australian Register of Therapeutic Goods....
listed medicinestherapeuticgoodsadministrationtga
https://www.tga.gov.au/products/medicines/listed-medicines/application-and-market-authorisation/listed-medicines-training
Listed medicines training | Therapeutic Goods Administration (TGA)
Oct 18, 2025 - Access learning modules to help you understand how to use the Evidence Guidelines.
listed medicinestrainingtherapeuticgoodsadministration
https://www.tga.gov.au/products/medicines/registered-complementary-medicines/application-and-market-authorisation/other-resources-sponsors-listed-medicines-and-registered-complementary-medicines
Other resources for sponsors of listed medicines and registered complementary medicines |...
Oct 18, 2025 - Resources for sponsors of listed medicines and registered complementary medicines
other resourcesfor sponsorslisted medicinesregisteredcomplementary
https://www.miragenews.com/efficacy-of-listed-medicines-for-exercise-1668968/
Efficacy Of Listed Medicines For Exercise Performance | Mirage News
The TGA initiated targeted compliance reviews of select listed medicines containing Magnesium to verify whether sponsors had appropriate evidence to
efficacy oflisted medicinesfor exerciseperformancemirage
https://www.tga.gov.au/products/medicines/listed-medicines/monitoring-and-compliance/compliance-and-education-listed-medicines/listed-medicines-containing-mollusc-derived-ingredients-requiring-warning-statements
Listed medicines containing mollusc-derived ingredients requiring warning statements | Therapeutic...
Oct 27, 2025 - In 2024, we initiated targeted compliance reviews of selected listed medicines that required warning statements on their labels as they contained...
listed medicinescontainingmolluscderivedingredients
https://www.tga.gov.au/news/news-articles/listed-medicines-requiring-warning-statement
Listed medicines requiring a warning statement | Therapeutic Goods Administration (TGA)
Nov 4, 2025 - We will be initiating targeted compliance reviews of selected listed medicines that are required to display a warning statement
listed medicinesa warningrequiringstatementtherapeutic
https://www.tga.gov.au/products/medicines/listed-medicines/monitoring-and-compliance/compliance-and-education-listed-medicines
Compliance and education for listed medicines | Therapeutic Goods Administration (TGA)
May 7, 2026 - Find out about our compliance review activities for listed medicines and how to avoid common compliance issues.
compliance and educationlisted medicinestherapeuticgoodsadministration
https://www.tga.gov.au/products/medicines/assessed-listed-medicines/monitoring-and-compliance
Monitoring and compliance for assessed listed medicines | Therapeutic Goods Administration (TGA)
Oct 29, 2025 - Understand your ongoing post-market responsibilities for assessed listed medicines.
monitoring and complianceassessed listed medicines
https://www.tga.gov.au/products/medicines/listed-medicines/monitoring-and-compliance/compliance-and-education-listed-medicines/listed-medicines-requiring-pregnancy-warning-statement
Listed medicines requiring a pregnancy warning statement | Therapeutic Goods Administration (TGA)
Oct 31, 2025 - We will be initiating targeted compliance reviews of selected listed medicines that require warning statements related to use during pregnancy.
listed medicineswarning statementrequiringpregnancy
https://www.tga.gov.au/resources/resources/user-guide/evaluation-substances-use-listed-medicines-and-assessed-listed-medicines-user-guide
Evaluation of substances for use in listed medicines and assessed listed medicines: user guide |...
Oct 10, 2025 - A user guide for applicants using the TGA Business services (TBS) portal to complete an online application form for a new substance application.
for use
https://www.tga.gov.au/resources/guidance/sampling-and-testing-listed-and-complementary-medicines
Sampling and testing for listed and complementary medicines | Therapeutic Goods Administration (TGA)
Jan 5, 2026 - Guidance for interpreting the Pharmaceutical Inspection Co-operation Scheme (PIC/S) guide to good manufacturing practice (GMP) for medicinal products.
complementary medicinessamplingtestinglisted
https://www.tga.gov.au/products/medicines/listed-medicines/monitoring-and-compliance/compliance-and-education-listed-medicines/listed-medicines-are-required-be-tested-presence-aristolochic-acids
Listed medicines that are required to be tested for the presence of Aristolochic acids |...
Apr 10, 2026 - Updated information on requirement to test for presence of aristolochic acids in certain listed medicines
https://www.tga.gov.au/resources/guidance/demonstrating-quality-listed-probiotic-medicines
Demonstrating the quality of listed probiotic medicines | Therapeutic Goods Administration (TGA)
Jan 5, 2026 - Guidance for sponsors and manufacturers to meet the technical, scientific and regulatory requirements to ensure the quality of probiotic medicine acceptable...
the qualitydemonstratinglisted